Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
Open Access
- 14 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (12), 1-16
- https://doi.org/10.1038/s41419-020-03271-6
Abstract
The excessive accumulation of extracellular matrix (ECM) is a key feature of liver fibrosis and the activated hepatic stellate cells (HSCs) are the major producer of ECM proteins. However, the precise mechanisms and target molecules that are involved in liver fibrosis remain unclear. In this study, we reported that activating transcription factor 3 (ATF3) was over-expressed in mice and human fibrotic livers, in activated HSCs and injured hepatocytes (HCs). Both in vivo and in vitro study have revealed that silencing ATF3 reduced the expression of pro-fibrotic genes and inhibited the activation of HSCs, thus alleviating the extent of liver fibrosis, indicating a potential protective role of ATF3 knockdown. However, ATF3 was not involved in either the apoptosis or proliferation of HCs. In addition, our data illustrated that increased nuclear localization of ATF3 promoted the transcription of fibrogenic genes and lnc-SCARNA10, which functioned as a novel positive regulator of TGF-β signaling in liver fibrogenesis by recruiting SMAD3 to the promoter of these genes. Interestingly, further study also demonstrated that lnc-SCARNA10 promoted the expression of ATF3 in a TGF-β/SMAD3-dependent manner, revealing a TGF-β/ATF3/lnc-SCARNA10 axis that contributed to liver fibrosis by activating HSCs. Taken together, our data provide a molecular mechanism implicating induced ATF3 in liver fibrosis, suggesting that ATF3 may represent a useful target in the development of therapeutic strategies for liver fibrosis.Keywords
This publication has 45 references indexed in Scilit:
- β-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrixCell Death & Disease, 2020
- Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosisCell Death & Disease, 2020
- Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosisTheranostics, 2020
- Molecular pathways of nonalcoholic fatty liver disease development and progressionCellular and Molecular Life Sciences, 2018
- The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathwaysNature Communications, 2017
- Mechanisms of hepatic stellate cell activationNature Reviews Gastroenterology & Hepatology, 2017
- The circular RNA ciRS‐7 promotes APP and BACE1 degradation in an NF‐κB‐dependent mannerThe FEBS Journal, 2017
- TSC1 Activates TGF-β-Smad2/3 Signaling in Growth Arrest and Epithelial-to-Mesenchymal TransitionDevelopmental Cell, 2015
- Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosisNature Medicine, 2015
- Role for Activating Transcription Factor 3 in Stress-Induced β-Cell ApoptosisMolecular and Cellular Biology, 2004